Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HARTFORD INSURANCE GROUP, INC.HIG · Entity 3092 | President | May 27, 2026 | May 29, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HARTFORD INSURANCE GROUP, INC.
Report date May 27, 2026 · Filed May 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 38,208.27 |
Ending reported balance
After 2026-05-27 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-05-27 · Exercise / conversion · Acquired 8,895 · Balance 47,103.27 Row 2 · 2026-05-27 · Sale · Disposed 8,895 · Balance 38,208.27 F1: The transaction reported on this Form 4 was effected pursuant to a trading plan previously adopted by Mr. Tooker on August 25, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $49.01 · Expires 2029-02-26 | Direct | 17,792 |
Reported balance
After 2026-05-27 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-05-27 · Exercise / conversion · Disposed 8,895 · Balance 17,792 F2: The options became fully exercisable on February 26, 2022, the third anniversary of the grant date. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $51.87 · Expires 2031-02-23 | Direct | 25,202 |
Reported balance
Holding disclosure · report date 2026-05-27 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 25,202 F3: The options became fully exercisable on February 23, 2024, the third anniversary of the grant date. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $53.81 · Expires 2028-02-27 | Direct | 8,307 |
Reported balance
Holding disclosure · report date 2026-05-27 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 8,307 F4: The options became fully exercisable on February 27, 2021, the third anniversary of the grant date. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $55.27 · Expires 2030-02-25 | Direct | 24,094 |
Reported balance
Holding disclosure · report date 2026-05-27 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 24,094 F5: The options became fully exercisable on February 25, 2023, the third anniversary of the grant date. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $69.41 · Expires 2032-02-23 | Direct | 24,155 |
Reported balance
Holding disclosure · report date 2026-05-27 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 24,155 F6: The options became fully exercisable on February 23, 2025, the third anniversary of the grant date. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $78.28 · Expires 2033-02-28 | Direct | 24,301 |
Reported balance
Holding disclosure · report date 2026-05-27 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 24,301 F7: The options became fully exercisable on February 28, 2026, the third anniversary of the grant date. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $95.74 · Expires 2034-02-27 | Direct | 16,492 |
Reported balance
Holding disclosure · report date 2026-05-27 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 16,492 F8: One-third of the options became exercisable on February 27, 2025, an additional one-third of the options became exercisable on February 27, 2026 and the remaining one-third of the options will become exercisable on February 27, 2027, the third anniversary of the grant date. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $116.41 · Expires 2035-02-25 | Direct | 25,488 |
Reported balance
Holding disclosure · report date 2026-05-27 · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · Balance 25,488 F9: One-third of the options became exercisable on February 25, 2026, an additional one-third of the options will become exercisable on February 25, 2027 and the remaining one-third of the options will become exercisable on February 25, 2028, the third anniversary of the grant date. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $140.54 · Expires 2036-02-24 | Direct | 28,982 |
Reported balance
Holding disclosure · report date 2026-05-27 · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · Balance 28,982 F10: One-third of the options will become exercisable on February 24, 2027, an additional one-third of the options will become exercisable on February 24, 2028 and the remaining one-third of the options will become exercisable on February 24, 2029, the third anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: The transaction reported on this Form 4 was effected pursuant to a trading plan previously adopted by Mr. Tooker on August 25, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
F2: The options became fully exercisable on February 26, 2022, the third anniversary of the grant date.
F3: The options became fully exercisable on February 23, 2024, the third anniversary of the grant date.
F4: The options became fully exercisable on February 27, 2021, the third anniversary of the grant date.
F5: The options became fully exercisable on February 25, 2023, the third anniversary of the grant date.
F6: The options became fully exercisable on February 23, 2025, the third anniversary of the grant date.
F7: The options became fully exercisable on February 28, 2026, the third anniversary of the grant date.
F8: One-third of the options became exercisable on February 27, 2025, an additional one-third of the options became exercisable on February 27, 2026 and the remaining one-third of the options will become exercisable on February 27, 2027, the third anniversary of the grant date.
F9: One-third of the options became exercisable on February 25, 2026, an additional one-third of the options will become exercisable on February 25, 2027 and the remaining one-third of the options will become exercisable on February 25, 2028, the third anniversary of the grant date.
F10: One-third of the options will become exercisable on February 24, 2027, an additional one-third of the options will become exercisable on February 24, 2028 and the remaining one-third of the options will become exercisable on February 24, 2029, the third anniversary of the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 23, 2023 Filed Feb 27, 2023 21:26 UTC | HARTFORD INSURANCE GROUP, INC. HIG · Entity 3092 | SaleCommon Stock | 3,920 | $77.41 | $303,447.20 |
DisclosureSEC source: 0001225208-23-002883 · doc4.xml · nonDerivative · entry 1 TOOKER ADIN M · CIK 0001953211 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,820.057 F1 · kind: The transaction reported on this Form 4 was effected pursuant to a trading plan previously adopted by Mr. Tooker on November 2, 2022 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| February 22, 2023 Filed Feb 22, 2023 22:51 UTC | HARTFORD INSURANCE GROUP, INC. HIG · Entity 3092 | Tax withholdingCommon Stock | 3,472 | $78.45 | $272,378.40 |
DisclosureSEC source: 0001225208-23-002562 · doc4.xml · nonDerivative · entry 2 TOOKER ADIN M · CIK 0001953211 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,740.057 F2 · kind: Transaction involving a disposition to the Company of equity securities to cover tax withholding obligations arising from the performance share certification reported on this Form 4, in accordance with the Company's administrative rules. F3 · price: The closing price of the Company's common stock on February 17, 2023, the last trading day prior to certification. Read SEC document |
| February 20, 2023 Filed Feb 22, 2023 22:51 UTC | HARTFORD INSURANCE GROUP, INC. HIG · Entity 3092 | Exercise / conversionPerformance Shares · Derivative | 7,392.637 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-002562 · doc4.xml · derivative · entry 4 TOOKER ADIN M · CIK 0001953211 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,392.637 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On February 20, 2023, the Company's Compensation and Management Development Committee certified a performance share payout based on the level of the Company's performance relative to pre-established objectives for the January 1, 2020 through December 31, 2022 performance period. The performance shares were paid in shares of the Company's common stock. F1 · derivative.exercise_date: On February 20, 2023, the Company's Compensation and Management Development Committee certified a performance share payout based on the level of the Company's performance relative to pre-established objectives for the January 1, 2020 through December 31, 2022 performance period. The performance shares were paid in shares of the Company's common stock. F1 · derivative.expiration_date: On February 20, 2023, the Company's Compensation and Management Development Committee certified a performance share payout based on the level of the Company's performance relative to pre-established objectives for the January 1, 2020 through December 31, 2022 performance period. The performance shares were paid in shares of the Company's common stock. Read SEC document |
| February 20, 2023 Filed Feb 22, 2023 22:51 UTC | HARTFORD INSURANCE GROUP, INC. HIG · Entity 3092 | GrantPerformance Shares · Derivative | 7,392.637 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-002562 · doc4.xml · derivative · entry 3 TOOKER ADIN M · CIK 0001953211 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,392.637 Underlying: Common Stock · 7,392.637 shares Expires not disclosed F1 · derivative.exercise_price: On February 20, 2023, the Company's Compensation and Management Development Committee certified a performance share payout based on the level of the Company's performance relative to pre-established objectives for the January 1, 2020 through December 31, 2022 performance period. The performance shares were paid in shares of the Company's common stock. F1 · derivative.exercise_date: On February 20, 2023, the Company's Compensation and Management Development Committee certified a performance share payout based on the level of the Company's performance relative to pre-established objectives for the January 1, 2020 through December 31, 2022 performance period. The performance shares were paid in shares of the Company's common stock. F1 · derivative.expiration_date: On February 20, 2023, the Company's Compensation and Management Development Committee certified a performance share payout based on the level of the Company's performance relative to pre-established objectives for the January 1, 2020 through December 31, 2022 performance period. The performance shares were paid in shares of the Company's common stock. Read SEC document |
| February 20, 2023 Filed Feb 22, 2023 22:51 UTC | HARTFORD INSURANCE GROUP, INC. HIG · Entity 3092 | Exercise / conversionCommon Stock | 7,392.637 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-002562 · doc4.xml · nonDerivative · entry 1 TOOKER ADIN M · CIK 0001953211 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,212.057 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On February 20, 2023, the Company's Compensation and Management Development Committee certified a performance share payout based on the level of the Company's performance relative to pre-established objectives for the January 1, 2020 through December 31, 2022 performance period. The performance shares were paid in shares of the Company's common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.